Neurology

Treating COVID-19 patients under the most challenging physical and emotional conditions has led to a sense of moral injury for many providers, according to Dr Michael Myers.

Prevalence of depression in the US has increased nearly 3-fold since before COVID-19. Here, a primer on the best assessment tools for depression diagnosis in primary care.

A psychiatrist who exclusively treats health care providers describes his work during the pandemic with clinicians who are treating COVID-19 patients.

Pandemic conditions are daily life for healthcare professionals, but addressing the distress and despair among friends, family, and colleagues can be a challenge.

Pain specialist Steven King, MD, highlights a new review that looks at the complex, bidirectional relationship between sleep disturbance and chronic pain.

A first aid guide for caregivers, an app that allows patients to track epilepsy trends, and 3 more top epilepsy and seizure apps for primary care.

New research shows nearly 30% of US young adults do not know the 5 most common stroke symptoms, almost 3 million are not aware of any symptoms.

The association of vascular dementia with T2D is stronger than that of nonvascular or Alzheimer dementia, according to a study presented at EASD.

Youth who experienced weight stigma prior to COVID-19 were 3-times more likely to engage in binge eating during the pandemic vs those who had not, a new study found.

Survey: Most US adults feel COVID-19 has made it essential to talk openly about suicide; more than half say it has made them more open to discussing mental health.

A new study found that brief mindfulness-based programs can reduce stress and anxiety among US health care professionals.

The CDC reports an alarming level of pandemic-related psychological and behavioral distress including thoughts of suicide across US population segments.

In episode 1 of Primary Viewpoints, migraine specialist Peter McAllister, MD, discusses how the COVID-19 pandemic has impacted his migraine patients.

A survey of >15 000 UK respondents found people who have or had COVID-19 are more likely to develop general psychiatric disorders and loneliness.

How has the COVID-19 pandemic impacted migraine patients? We asked 3 migraine specialists that question and more.

Ketamine used in patients with treatment-resistant depression operates via serotonin 1B receptors by way of a previously unknown mechanism of action, according to a new study from Sweden.

Incident cardiovascular disease is significantly increased among women with migraine with aura vs migraineurs without aura and those who do not have migraine.

Analysis of data from more than 21 000 migraineurs found that less than 1 in 3 take prescribed acute medications and less than 1 in 5 take prescribed preventive agents.

As neurologic findings among patients with COVID-19 emerge, comparison to sequelae seen with other coronaviruses is instructive.

Over half of US adults who responded to a new survey said COVID-19 has impacted their mental health. To what extent? Find out in our new slideshow.

Almost half of Americans are anxious about contracting COVID-19, suggests a new American Psychiatric Association poll. More results at-a-glance here.

Frontline medical workers dealing with COVID-19 in China have a high risk of developing symptoms of depression, anxiety, insomnia, and distress.

Mental illness affects 1 in 5 US adults every year; some of them are your patients. This brief study of "the numbers" is essential.

Two first-in-class migraine drugs, the first generic version of NuvaRing®, and 7 more fourth quarter FDA-approved drugs for primary care.

A new study found a significant association between increased stroke risk and dual use of e-cigarettes and traditional cigarettes-authors urging physicians to use results as a wake-up call.